reference/1753817

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/1753817

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, Non-U.S. Gov't
endingPage	309
issn	1098-2744 0899-1987
issueIdentifier	4
pageRange	301-309
publicationName	Molecular Carcinogenesis
startingPage	301
bibliographicCitation	Matsuyama Y, Suzuki M, Arima C, Huang QM, Tomida S, Takeuchi T, Sugiyama R, Itoh Y, Yatabe Y, Goto H, Takahashi T. Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas. Mol Carcinog. 2011 Apr;50(4):301–9. doi: 10.1002/mc.20632. PMID: 21465578.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f460cd70ff9d9947c2b2626090aa7e4a http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-1788-559X http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f90f49d72ed9e6c643cc468b20fa757e http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c620c80bb2f68f8225fbb8fed6a37b5a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5dc9f87219126a73a06b066d7dc4ec75 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_99f8dcb1d6c236b2cd51f3a2e171e1b9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89d3c64a2124588084c54313bacfadde http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_95f8776dea5300f5ed70f7e1a55654ec http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f4235faea758e89e712933cc9e568463 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2914fc2b62d2d243e023f719213c0751 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-0615-7001 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e92817790d12f104e674294abb88322a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f3f48315ad53511c8ec79432e85422d7
date	201104
identifier	https://pubmed.ncbi.nlm.nih.gov/21465578 https://doi.org/10.1002/mc.20632
isPartOf	https://portal.issn.org/resource/ISSN/1098-2744 https://portal.issn.org/resource/ISSN/0899-1987 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1399
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Proteasomal non‐catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas
discusses	http://id.nlm.nih.gov/mesh/M0234432 http://id.nlm.nih.gov/mesh/M0460355 http://id.nlm.nih.gov/mesh/M0265702 http://id.nlm.nih.gov/mesh/M0150739 http://id.nlm.nih.gov/mesh/M0140424 http://id.nlm.nih.gov/mesh/M0235451
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000230Q000378 http://id.nlm.nih.gov/mesh/D047988Q000378 http://id.nlm.nih.gov/mesh/D008175Q000378 http://id.nlm.nih.gov/mesh/D046988Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D034622 http://id.nlm.nih.gov/mesh/D009367 http://id.nlm.nih.gov/mesh/D053208 http://id.nlm.nih.gov/mesh/D015153 http://id.nlm.nih.gov/mesh/D008175Q000235 http://id.nlm.nih.gov/mesh/D017209 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018628 http://id.nlm.nih.gov/mesh/D010766 http://id.nlm.nih.gov/mesh/D047988Q000235 http://id.nlm.nih.gov/mesh/D051057Q000378 http://id.nlm.nih.gov/mesh/D000230Q000235 http://id.nlm.nih.gov/mesh/D000230Q000473 http://id.nlm.nih.gov/mesh/D049109 http://id.nlm.nih.gov/mesh/D020869 http://id.nlm.nih.gov/mesh/D016000 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D047992 http://id.nlm.nih.gov/mesh/D008175Q000473 http://id.nlm.nih.gov/mesh/D011379 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D048051Q000378 http://id.nlm.nih.gov/mesh/D002460
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6650 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_472b28cee6c37ce9d58de4aa1dc6d7ef http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4364cf21c8950e29e0eef7c8157371bc http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8366 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_24fcc8ae2c4a3fc4fe2b5ecda59a20f4 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_f585b870d33faa218f7c1f6f58dd3c9e http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_e7c5ddf51598d2addf7ca974bdff068d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_582d5f2f504253c89e3a8210d6134600 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fe0d872c4ea3e7d9f07488fc82841cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.25.1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_4f7d7fa31aa868be14ce6001ac82fcf7 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6795 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_75be19437755fc2af3f5756d6bb1d737 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bf99a94c673fe4e93461af6be7e99f9e

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5708

Total number of triples: 83.